Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Sunshine Biopharma (SBFM)

Sunshine Biopharma (SBFM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,669
  • Shares Outstanding, K 1,224
  • Annual Sales, $ 24,090 K
  • Annual Income, $ -4,510 K
  • EBIT $ -5 M
  • EBITDA $ -5 M
  • 60-Month Beta 1.38
  • Price/Sales 0.12
  • Price/Cash Flow N/A
  • Price/Book 0.11

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr N/A
See More
  • Average Estimate N/A
  • Number of Estimates N/A
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year N/A
  • Growth Rate Est. (year over year) N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.14 +0.70%
on 11/21/24
3.19 -32.44%
on 10/22/24
-0.90 (-29.58%)
since 10/21/24
3-Month
2.14 +0.70%
on 11/21/24
3.75 -42.53%
on 09/20/24
-0.87 (-28.64%)
since 08/21/24
52-Week
2.14 +0.70%
on 11/21/24
637.20 -99.66%
on 11/27/23
-477.64 (-99.55%)
since 11/21/23

Most Recent Stories

More News
New Research Reveals Emergence of New Variants of Coronavirus to Boost COVID-19 Therapeutics Market Growth

EQNX::TICKER_START (NASDAQ:SBFM),(NASDAQ:NVAX),(NASDAQ:RGNX),(NASDAQ:BNTX),(NYSE:ABBV) EQNX::TICKER_END

SBFM : 2.16 (-1.15%)
NVAX : 8.12 (+0.74%)
RGNX : 9.17 (-4.78%)
BNTX : 103.60 (+1.43%)
ABBV : 170.80 (+1.81%)
New Research Reveals Emergence of New Variants of Coronavirus to Boost COVID-19 Therapeutics Market Growth

SBFM : 2.16 (-1.15%)
NVAX : 8.12 (+0.74%)
RGNX : 9.17 (-4.78%)
BNTX : 103.60 (+1.43%)
ABBV : 170.80 (+1.81%)
Global Coronavirus Therapeutics Market Size Projected to Exceed $16 Billion By the End of 2031

EQNX::TICKER_START (NASDAQ:SBFM),(NASDAQ:MRNA),(NYSE:PFE),(NASDAQ:VIR),(NASDAQ:INO) EQNX::TICKER_END

SBFM : 2.16 (-1.15%)
MRNA : 36.73 (-0.57%)
PFE : 24.95 (+0.04%)
INO : 4.16 (+4.79%)
VIR : 6.68 (-0.89%)
Global Coronavirus Therapeutics Market Size Projected to Exceed $16 Billion By the End of 2031

SBFM : 2.16 (-1.15%)
MRNA : 36.73 (-0.57%)
PFE : 24.95 (+0.04%)
INO : 4.16 (+4.79%)
VIR : 6.68 (-0.89%)
SUNSHINE BIOPHARMA ANNOUNCES PUBLICATION OF SIGNIFICANT CORONAVIRUS RESEARCH RESULTS IN THE JOURNAL OF MEDICINAL CHEMISTRY

Current Test Positivity Rate for Coronavirus Infection in the U.S. is 18% Development of a novel antiviral compound, XR8-23 (Compound 10), targeting SARS-CoV-2 papain-like protease (PLpro) with both submicromolar...

SBFM : 2.16 (-1.15%)
Coronavirus Vaccine Market To Surpass $95 Billion By 2028

EQNX::TICKER_START (NASDAQ:SBFM),(NASDAQ:MRNA),(NASDAQ:NVAX),(NASDAQ:VIR),(NASDAQ:INO) EQNX::TICKER_END

SBFM : 2.16 (-1.15%)
MRNA : 36.73 (-0.57%)
NVAX : 8.12 (+0.74%)
VIR : 6.68 (-0.89%)
INO : 4.16 (+4.79%)
Coronavirus Vaccine Market To Surpass $95 Billion By 2028

/PRNewswire/ -- The Coronavirus Global Market has been growing in the past few years and is anticipated to continue to grow in the next several years. In fact,...

SBFM : 2.16 (-1.15%)
MRNA : 36.73 (-0.57%)
NVAX : 8.12 (+0.74%)
VIR : 6.68 (-0.89%)
INO : 4.16 (+4.79%)
SUNSHINE BIOPHARMA SIGNS EXCLUSIVE WORLDWIDE LICENSE WITH UNIVERSITY OF ARIZONA FOR PLpro-BASED COVID-19 TREATMENT

Montreal – February 28, 2023 – Sunshine Biopharma Inc. (NASDAQ: SBFM), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology and...

SBFM : 2.16 (-1.15%)
One in Five Americans Who Have Been Infected With the Virus Said to Have Long COVID

/PRNewswire/ -- Research and development is still focused on trying to help understand the acute infection 9itself and the effects of long COVID as well. As...

OCEL : 2.7500 (unch)
RGNX : 9.17 (-4.78%)
SBFM : 2.16 (-1.15%)
ABBV : 170.80 (+1.81%)
RVNC : 3.88 (+2.11%)
One in Five Americans Who Have Been Infected With the Virus Said to Have Long COVID

Palm Beach, FL – November 17, 2022 – FinancialNewsMedia.com News Commentary – Since the beginning of the pandemic, the critical effort of researchers is to understand how coronavirus damages the...

SBFM : 2.16 (-1.15%)
ABBV : 170.80 (+1.81%)
OCEL : 2.7500 (unch)
RGNX : 9.17 (-4.78%)
RVNC : 3.88 (+2.11%)

Business Summary

Sunshine Biopharma Inc. is a pharmaceutical company. It focused on the research, development and commercialization of oncology and antiviral drugs. Sunshine Biopharma Inc. is based in MONTREAL.

See More

Key Turning Points

3rd Resistance Point 2.44
2nd Resistance Point 2.39
1st Resistance Point 2.28
Last Price 2.16
1st Support Level 2.13
2nd Support Level 2.08
3rd Support Level 1.97

See More

52-Week High 637.20
Fibonacci 61.8% 394.61
Fibonacci 50% 319.67
Fibonacci 38.2% 244.73
Last Price 2.16
52-Week Low 2.14

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar